VarunKart Group sells unapproved Ayurvedic and homeopathic drugs with serious disease claims.
What happened
In September 2025, FDA reviewed the Organic Wellnesses website and found nine products offered for sale with labeling claims to cure, mitigate, treat, or prevent serious conditions such as measles, tuberculosis, cancer, diabetes, and hepatitis, plus two eye drops. FDA concluded the products are drugs and unapproved new drugs because no FDA-approved applications are in effect.
What FDA found
The products are unapproved new drugs sold without FDA-approved applications.
FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)Website labeling shows the products are intended to cure, mitigate, treat, or prevent disease, making them drugs.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1); 21 CFR 201.128The products are new drugs because they are not generally recognized as safe and effective for their labeled uses.
FD&C Act section 201(p), 21 U.S.C. 321(p)Homeopathic products are not exempt from drug approval requirements.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
What FDA wants
Within 15 working days of receipt, notify FDA in writing of the specific steps taken to correct the violations, explain steps to prevent recurrence, and include related documentation. If corrective action cannot be completed within 15 working days, state the reason for delay and the time within which it will be completed, sending the response to FDAAdvisory@fda.hhs.gov with firm name and identifier 716154.
Who should pay attention
- online retailers of imported Ayurvedic or homeopathic products
- marketplaces and brands that publish disease-treatment claims
- consumers using eye drops or products claiming to treat serious diseases
This is a summary. Read the original letter on fda.gov.